248 related articles for article (PubMed ID: 31116478)
1. Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy.
Happersett L; Wang P; Zhang P; Mechalakos J; Li G; Eley E; Zelefsky M; Mageras G; Damato AL; Hunt M
J Appl Clin Med Phys; 2019 Jun; 20(6):120-124. PubMed ID: 31116478
[TBL] [Abstract][Full Text] [Related]
2. Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapy.
Zhang P; Happersett L; Ravindranath B; Zelefsky M; Mageras G; Hunt M
Med Phys; 2016 May; 43(5):2024. PubMed ID: 27147314
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous MV-kV imaging for intrafractional motion management during volumetric-modulated arc therapy delivery.
Hunt MA; Sonnick M; Pham H; Regmi R; Xiong JP; Morf D; Mageras GS; Zelefsky M; Zhang P
J Appl Clin Med Phys; 2016 Mar; 17(2):473-486. PubMed ID: 27074467
[TBL] [Abstract][Full Text] [Related]
4. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
Korpics MC; Rokni M; Degnan M; Aydogan B; Liauw SL; Redler G
J Appl Clin Med Phys; 2020 Mar; 21(3):184-191. PubMed ID: 31981305
[TBL] [Abstract][Full Text] [Related]
5. Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine megavoltage images during volumetric modulated arc therapy.
Azcona JD; Li R; Mok E; Hancock S; Xing L
Med Phys; 2013 Mar; 40(3):031708. PubMed ID: 23464303
[TBL] [Abstract][Full Text] [Related]
6. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
[TBL] [Abstract][Full Text] [Related]
7. Current modulated volume-of-interest imaging for kilovoltage intrafaction monitoring of the prostate.
Parsons D; Stevens MT; Robar JL
Med Phys; 2017 Apr; 44(4):1479-1493. PubMed ID: 28133744
[TBL] [Abstract][Full Text] [Related]
8. Time and frequency to observe fiducial markers in MLC-modulated fields during prostate IMRT/VMAT beam delivery.
Xu Q; Tong X; Lin M; Chen X; ElDib A; Lin T; Chen L; Ma CC
Phys Med; 2020 Aug; 76():142-149. PubMed ID: 32679409
[TBL] [Abstract][Full Text] [Related]
9. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
[TBL] [Abstract][Full Text] [Related]
10. Modelling of a novel technique to improve the visualisation of implanted fiducial markers for intra-fraction MV imaging of prostate VMAT targets.
Aland T; Jones M; Aho J; Kairn T; Trapp J
Biomed Phys Eng Express; 2021 Jul; 7(5):. PubMed ID: 34265752
[No Abstract] [Full Text] [Related]
11. Image-based dynamic multileaf collimator tracking of moving targets during intensity-modulated arc therapy.
Poulsen PR; Fledelius W; Cho B; Keall P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e265-71. PubMed ID: 22401924
[TBL] [Abstract][Full Text] [Related]
12. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer.
Li MH; Huang SF; Chang CC; Lin JC; Tsai JT
J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625
[TBL] [Abstract][Full Text] [Related]
13. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric adaptive IMRT driven by fiducial points.
Crijns W; Van Herck H; Defraene G; Van den Bergh L; Slagmolen P; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2014 Jun; 41(6):061716. PubMed ID: 24877811
[TBL] [Abstract][Full Text] [Related]
15. Constrained optimization towards marker-based tumor tracking in VMAT.
Omotayo A; Venkataraman S; McCurdy B
Biomed Phys Eng Express; 2020 Dec; 7(1):. PubMed ID: 35013009
[TBL] [Abstract][Full Text] [Related]
16. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
[TBL] [Abstract][Full Text] [Related]
17. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
[TBL] [Abstract][Full Text] [Related]
18. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
Eminowicz G; Dean C; Shoffren O; Macdougall N; Wells P; Muirhead R
Br J Radiol; 2014 May; 87(1037):20130696. PubMed ID: 24646126
[TBL] [Abstract][Full Text] [Related]
20. Online 4D ultrasound guidance for real-time motion compensation by MLC tracking.
Ipsen S; Bruder R; O'Brien R; Keall PJ; Schweikard A; Poulsen PR
Med Phys; 2016 Oct; 43(10):5695. PubMed ID: 27782689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
